Trial NCT02366663

View at ClinicalTrials.gov 
Org. Study IDs: 12338
Secondary IDs: NCI-2015-00185

Last trial update was posted on 2018-03-12

MeSH Interventions

Carmustine Cytarabine Etoposide Melphalan Rituximab

MeSH Conditions

Lymphoma Lymphoma, B-Cell Lymphoma, Large B-Cell, Diffuse

Other Conditions

Recurrent Diffuse Large B-Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma

Stopping Reasons

Withdrawal of sponsor support

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID